Cargando…
Successful treatment for sorafenib-induced liver dysfunction: a report of case with liver biopsy
Sorafenib is an oral multikinase inhibitor with anti-proliferative and anti-angiogenic effects and is used worldwide for the treatment of advanced or metastatic hepatocellular carcinoma (HCC). While the significant survival benefit of sorafenib in patients with advanced HCC was demonstrated, various...
Autores principales: | Kuroda, Daisuke, Hayashi, Hiromitsu, Nitta, Hidetoshi, Imai, Katsunori, Abe, Shinya, Hashimoto, Daisuke, Chikamoto, Akira, Ishiko, Takatoshi, Beppu, Toru, Baba, Hideo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713402/ https://www.ncbi.nlm.nih.gov/pubmed/26943680 http://dx.doi.org/10.1186/s40792-016-0131-z |
Ejemplares similares
-
Reactive lymphoid hyperplasia of the liver requires differential diagnosis of hepatocellular carcinoma
por: Higashi, Takaaki, et al.
Publicado: (2015) -
A 5-year recurrence-free survivor with over ten colorectal liver metastases undergoing FOLFOX plus bevacizumab followed by two-stage hepatectomy
por: Tamaoki, Yuka, et al.
Publicado: (2015) -
Hepatic angiomyolipoma with special attention to radiologic imaging
por: Kuramoto, Kunitaka, et al.
Publicado: (2015) -
The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma
por: Beppu, Toru, et al.
Publicado: (2017) -
Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer
por: Sakamoto, Keita, et al.
Publicado: (2015)